{{Rsnum
|rsid=4814615
|Gene=PCSK2
|Chromosome=20
|position=17376928
|Orientation=plus
|GMAF=0.2929
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=PCSK2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 1.8 | 22.1 | 76.1
| HCB | 28.5 | 48.9 | 22.6
| JPT | 26.5 | 38.9 | 34.5
| YRI | 3.4 | 31.3 | 65.3
| ASW | 1.8 | 43.9 | 54.4
| CHB | 28.5 | 48.9 | 22.6
| CHD | 26.6 | 50.5 | 22.9
| GIH | 1.0 | 16.8 | 82.2
| LWK | 5.5 | 26.4 | 68.2
| MEX | 22.4 | 44.8 | 32.8
| MKK | 2.6 | 30.8 | 66.7
| TSI | 2.0 | 35.6 | 62.4
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21546767
|Trait=None
|Title=Genome-wide association scan for survival on dialysis in african-americans with type 2 diabetes.
|RiskAllele=
|Pval=0.000005
|OR=1.5900
|ORtxt=[1.30-1.95]
|OA=1
}}

{{PMID|17903303|OA=1
}} Genome-wide association study for subclinical atherosclerosis in major arterial territories in the NHLBI's Framingham Heart Study.

{{PMID|17903303|OA=1
}} Genome-wide association study for subclinical atherosclerosis in major arterial territories in the NHLBI's Framingham Heart Study.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}